Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications
GC
1 other identifier
interventional
32
1 country
1
Brief Summary
The study has the purpose to evaluate the effectiveness and safety of the goniocurettage as a first choice of surgical treatment for primary open-angle glaucoma (POAG) in patients with good vision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jun 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 14, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedFirst Posted
Study publicly available on registry
January 18, 2012
CompletedJanuary 18, 2012
January 1, 2012
11 months
October 14, 2011
January 17, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intra Ocular Pressure
The mean of at least three measures at 8:00 am two weeks before surgery. After intervention, the Intra Ocular Pressure was measured on the day after, one week after, two weeks after and every month at the same time until the end of the study (an expected average of 20 months).
Change from Baseline in Intra Ocular Pressure at 20 months
Secondary Outcomes (3)
Central Corneal Thickness
Two weeks before, six months after and one year after intervention
Central corneal endothelial cell density
Two weeks before, six months after intervention and one year after intervention
Best correct visual acuity
Two weeks before, six months after and one year after intervention
Study Arms (1)
Eye Surgery
EXPERIMENTALGoniocurettage was used to treat open angle glaucoma patients
Interventions
Ab interno surgery consisting on scraped away the trabecular tissue from the angle (goniocurettage) removing segments of pathologically altered trabecular meshwork from the scleral sulcus
Eligibility Criteria
You may qualify if:
- Disc and/or visual field findings consistent with Primary Open Angle Glaucoma
- Uncontrolled intraocular pressure (≥21 mm Hg) or progressive glaucomatous neuropathy despite maximum tolerated medical therapy
- years old or over
- Visual acuity higher than 0.2
- Open angles (greater or equal to Shaffer grade II)
You may not qualify if:
- Previous ocular surgery
- History of glaucoma laser treatment
- History of ocular trauma
- Cyclodestructive procedures
- Corneal edema or opacities
- Endothelial decompensation
- History of uveitis
- Secondary glaucoma
- neovascularization of the iris or angle
- Congenital anterior segment abnormalities
- Anatomically confusing angles without clear definition of the scleral spur or meshwork and inability to maintain follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Minas Gerais
Belo Horizonte, Minas Gerais, 30130-100, Brazil
Related Publications (5)
Jacobi PC, Dietlein TS, Krieglstein GK. Technique of goniocurettage: a potential treatment for advanced chronic open angle glaucoma. Br J Ophthalmol. 1997 Apr;81(4):302-7. doi: 10.1136/bjo.81.4.302.
PMID: 9215060BACKGROUNDJacobi PC, Dietlein TS, Krieglstein GK. Goniocurettage for removing trabecular meshwork: clinical results of a new surgical technique in advanced chronic open-angle glaucoma. Am J Ophthalmol. 1999 May;127(5):505-10. doi: 10.1016/s0002-9394(98)00448-6.
PMID: 10334341BACKGROUNDJacobi PC, Dietlein TS, Krieglstein GK. Microendoscopic trabecular surgery in glaucoma management. Ophthalmology. 1999 Mar;106(3):538-44. doi: 10.1016/S0161-6420(99)90113-6.
PMID: 10080211BACKGROUNDJohnson DH, Johnson M. How does nonpenetrating glaucoma surgery work? Aqueous outflow resistance and glaucoma surgery. J Glaucoma. 2001 Feb;10(1):55-67. doi: 10.1097/00061198-200102000-00011.
PMID: 11219641BACKGROUNDMinckler D, Baerveldt G, Ramirez MA, Mosaed S, Wilson R, Shaarawy T, Zack B, Dustin L, Francis B. Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma. Trans Am Ophthalmol Soc. 2006;104:40-50.
PMID: 17471324BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tiago T Souza, MD
Federal University of Minas Gerais
- STUDY DIRECTOR
Sebastiao Cronemberger, PhD
Federal University of Minas Gerais
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 14, 2011
First Posted
January 18, 2012
Study Start
June 1, 2009
Primary Completion
May 1, 2010
Study Completion
January 1, 2012
Last Updated
January 18, 2012
Record last verified: 2012-01